Literature DB >> 15204154

Treatment of pityriasis versicolor in the United States.

L A Mellen1, J Vallee, S R Feldman, A B Fleischer.   

Abstract

BACKGROUND: Pityriasis versicolor is a common chronic superficial fungal infection of the skin.
OBJECTIVE: The purpose of this study is to determine the frequency of visits for pityriasis versicolor and to assess how it is currently being treated.
METHODS: Data from the National Ambulatory Medical Care survey were used from the years 1990-1999.
RESULTS: There were 2.9 million visits per year in which pityriasis (tinea) versicolor was listed as a diagnosis; this corresponds to a visit rate of 110 visits per 100,000 persons per year. Visit rates varied among racial and ethnic groups, with the highest visit rates for black people and American Indians/Eskimos. A total of 76% of the medications listed at visits for pityriasis versicolor are FDA approved for the condition; however, many treatments that were prescribed were not.
CONCLUSIONS: Given that as many as one-quarter of treatments prescribed for this easily treatable condition are inappropriate, continued education of medical practitioners concerning appropriate treatment options is needed.

Entities:  

Mesh:

Year:  2004        PMID: 15204154     DOI: 10.1080/09546630410032421

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  5 in total

1.  Antifungal agents for common paediatric infections.

Authors: 
Journal:  Paediatr Child Health       Date:  2007-12       Impact factor: 2.253

2.  Antifungal agents for common paediatric infections.

Authors: 
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

3.  Skin care in ethnic populations.

Authors:  Patrick D Cole; Daniel A Hatef; Susan Taylor; Jamal M Bullocks
Journal:  Semin Plast Surg       Date:  2009-08       Impact factor: 2.314

4.  Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study.

Authors:  Shaimaa El-Housiny; Maii Atef Shams Eldeen; Yasmina Ahmed El-Attar; Hoda A Salem; Dalia Attia; Ehab R Bendas; Mohamed A El-Nabarawi
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

Review 5.  Antifungal Treatment for Pityriasis Versicolor.

Authors:  Aditya K Gupta; Kelly A Foley
Journal:  J Fungi (Basel)       Date:  2015-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.